BRPI0911067B8 - métodos e sistemas para determinar a presença ou ausência de um analito em uma amostra de líquido - Google Patents

métodos e sistemas para determinar a presença ou ausência de um analito em uma amostra de líquido

Info

Publication number
BRPI0911067B8
BRPI0911067B8 BRPI0911067A BRPI0911067A BRPI0911067B8 BR PI0911067 B8 BRPI0911067 B8 BR PI0911067B8 BR PI0911067 A BRPI0911067 A BR PI0911067A BR PI0911067 A BRPI0911067 A BR PI0911067A BR PI0911067 B8 BRPI0911067 B8 BR PI0911067B8
Authority
BR
Brazil
Prior art keywords
methods
analyte
absence
systems
determining
Prior art date
Application number
BRPI0911067A
Other languages
English (en)
Portuguese (pt)
Inventor
C Curry Adam
Sandmann Christian
Weidemaier Kristin
Pederson Allphin Lori
Kuroda Melody
A Fulcher Robert
Original Assignee
Becton Dickinson Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Becton Dickinson Co filed Critical Becton Dickinson Co
Publication of BRPI0911067A2 publication Critical patent/BRPI0911067A2/pt
Publication of BRPI0911067B1 publication Critical patent/BRPI0911067B1/pt
Publication of BRPI0911067B8 publication Critical patent/BRPI0911067B8/pt

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366Apparatus specially adapted for solid-phase testing
    • G01N33/54373Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366Apparatus specially adapted for solid-phase testing
    • G01N33/54386Analytical elements
    • G01N33/54387Immunochromatographic test strips
    • G01N33/54388Immunochromatographic test strips based on lateral flow
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366Apparatus specially adapted for solid-phase testing
    • G01N33/54386Analytical elements
    • G01N33/54387Immunochromatographic test strips
    • G01N33/54391Immunochromatographic test strips based on vertical flow
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
    • G01N33/587Nanoparticles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
BRPI0911067A 2008-04-09 2009-04-08 métodos e sistemas para determinar a presença ou ausência de um analito em uma amostra de líquido BRPI0911067B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7103508P 2008-04-09 2008-04-09
US61/071.035 2008-04-09
PCT/US2009/039951 WO2009126735A1 (en) 2008-04-09 2009-04-08 Sensitive immunoassays using coated nanoparticles

Publications (3)

Publication Number Publication Date
BRPI0911067A2 BRPI0911067A2 (pt) 2015-12-29
BRPI0911067B1 BRPI0911067B1 (pt) 2020-10-20
BRPI0911067B8 true BRPI0911067B8 (pt) 2021-07-27

Family

ID=40756968

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0911067A BRPI0911067B8 (pt) 2008-04-09 2009-04-08 métodos e sistemas para determinar a presença ou ausência de um analito em uma amostra de líquido

Country Status (11)

Country Link
US (2) US20090305231A1 (enExample)
EP (2) EP2271939B1 (enExample)
JP (3) JP5792614B2 (enExample)
CN (2) CN102016585B (enExample)
AU (1) AU2009233755B2 (enExample)
BR (1) BRPI0911067B8 (enExample)
CA (1) CA2721064C (enExample)
ES (2) ES2627190T3 (enExample)
MX (1) MX2010011176A (enExample)
TW (1) TW200946913A (enExample)
WO (1) WO2009126735A1 (enExample)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090291508A1 (en) * 2008-05-20 2009-11-26 Rapid Pathogen Screening Inc. Nanoparticles in diagnostic tests
US8470608B2 (en) * 2008-05-20 2013-06-25 Rapid Pathogen Screening, Inc Combined visual/fluorescence analyte detection test
US8669052B2 (en) 2008-06-10 2014-03-11 Rapid Pathogen Screening, Inc. Lateral flow nucleic acid detector
US8609433B2 (en) 2009-12-04 2013-12-17 Rapid Pathogen Screening, Inc. Multiplanar lateral flow assay with sample compressor
US8962260B2 (en) 2008-05-20 2015-02-24 Rapid Pathogen Screening, Inc. Method and device for combined detection of viral and bacterial infections
US9068981B2 (en) 2009-12-04 2015-06-30 Rapid Pathogen Screening, Inc. Lateral flow assays with time delayed components
US20130196310A1 (en) 2008-05-20 2013-08-01 Rapid Pathogen Screening, Inc. Method and Device for Combined Detection of Viral and Bacterial Infections
US8815609B2 (en) 2008-05-20 2014-08-26 Rapid Pathogen Screening, Inc. Multiplanar lateral flow assay with diverting zone
US20110086359A1 (en) 2008-06-10 2011-04-14 Rapid Pathogen Screening, Inc. Lateral flow assays
US11377485B2 (en) 2009-12-02 2022-07-05 Academia Sinica Methods for modifying human antibodies by glycan engineering
US10087236B2 (en) 2009-12-02 2018-10-02 Academia Sinica Methods for modifying human antibodies by glycan engineering
US10338069B2 (en) * 2010-04-12 2019-07-02 Academia Sinica Glycan arrays for high throughput screening of viruses
WO2012051218A2 (en) * 2010-10-11 2012-04-19 Mbio Diagnostics, Inc. Fluidic assay cartridge with controlled passive flow
US10114020B2 (en) 2010-10-11 2018-10-30 Mbio Diagnostics, Inc. System and device for analyzing a fluidic sample
CA2778561C (en) * 2011-05-31 2020-10-13 Ghandi, Khashayar Magnetic nanocomposite material and processes for the production thereof
US9715579B2 (en) 2011-09-09 2017-07-25 Alverix, Inc. Distributed network of in-vitro diagnostic devices
US9524372B2 (en) 2011-09-09 2016-12-20 Alverix, Inc. In-vitro diagnostic device using external information in conjunction with test results
US10725033B2 (en) * 2012-01-31 2020-07-28 Regents Of The University Of Minnesota Lateral flow assays with thermal contrast readers
US10816492B2 (en) * 2012-01-31 2020-10-27 Regents Of The University Of Minnesota Lateral flow assays with thermal contrast readers
EP2884264B1 (en) 2012-08-10 2019-11-20 Hamamatsu Photonics K.K. Surface-enhanced raman scattering element, and method for producing same
CN104508466B (zh) 2012-08-10 2018-07-17 浜松光子学株式会社 表面增强拉曼散射元件
JP6151948B2 (ja) * 2013-03-29 2017-06-21 浜松ホトニクス株式会社 表面増強ラマン散乱ユニット及びラマン分光分析方法
EP2911791A4 (en) 2012-10-29 2016-11-02 Mbio Diagnostics Inc BIOPARTICLE IDENTIFICATION SYSTEM, CARTRIDGE AND RELATED METHODS
EP2811301B1 (en) 2012-11-15 2017-05-10 Ortho-Clinical Diagnostics, Inc. Quality/process control of a lateral flow assay device based on flow monitoring
KR102298172B1 (ko) 2013-09-06 2021-09-06 아카데미아 시니카 변화된 글리코실 그룹을 갖는 당지질을 사용한 인간 iNKT 세포 활성화
US10005847B2 (en) 2014-05-27 2018-06-26 Academia Sinica Anti-HER2 glycoantibodies and uses thereof
KR20240096599A (ko) 2014-05-27 2024-06-26 아카데미아 시니카 항-cd20 글리코항체 및 이의 용도
AU2015267052A1 (en) 2014-05-27 2016-12-15 Academia Sinica Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
JP7063538B2 (ja) 2014-05-28 2022-05-09 アカデミア シニカ 抗TNFα糖操作抗体群およびその使用
WO2016072806A2 (ko) 2014-11-06 2016-05-12 포항공과대학교 산학협력단 코어-쉘 구조의 페로브스카이트 나노결정입자 발광체, 이의 제조방법 및 이를 이용한 발광소자
US10495645B2 (en) 2015-01-16 2019-12-03 Academia Sinica Cancer markers and methods of use thereof
US10808287B2 (en) 2015-10-23 2020-10-20 Rapid Pathogen Screening, Inc. Methods and devices for accurate diagnosis of infections
CA3024569A1 (en) 2016-06-22 2017-12-28 Becton, Dickinson And Company Modular assay reader device
AU2017316663B2 (en) 2016-08-22 2024-02-22 CHO Pharma Inc. Antibodies, binding fragments, and methods of use
US10796901B2 (en) * 2016-09-29 2020-10-06 Nanoco Technologies Ltd. Shelling of halide perovskite nanoparticles for the prevention of anion exchange
CN110554018A (zh) * 2018-05-31 2019-12-10 上海市刑事科学技术研究院 检测水溶液中4-溴甲卡西酮的表面增强拉曼材料及其制备方法
CN111686826B (zh) * 2019-03-15 2023-05-23 国家纳米科学中心 分层结构的微流控芯片及其应用
JP7607312B2 (ja) * 2020-01-09 2024-12-27 国立大学法人山梨大学 標識化シリカコート金ナノロッド及びその製造方法
WO2021252810A1 (en) 2020-06-10 2021-12-16 Checkable Medical Incorporated In vitro diagnostic device
TWI756764B (zh) * 2020-07-31 2022-03-01 國立中興大學 光電流電極及光電免疫感測裝置
WO2022179647A1 (en) * 2021-02-24 2022-09-01 Univerzita Palackeho V Olomouci Test strip for surface-enhanced raman spectroscopy, method for its preparation and use thereof
US20220317124A1 (en) 2021-04-01 2022-10-06 Becton Dickinson And Company Methods for enhancing specificity and sensitivity of group a streptococcus immunoassay
TWI792554B (zh) * 2021-09-10 2023-02-11 財團法人工業技術研究院 鈣鈦礦前驅物溶液檢測法
WO2023055305A1 (en) * 2021-09-28 2023-04-06 National Science And Technology Development Agency Qualitative dextran detection device and use thereof
CN114720450A (zh) * 2022-03-29 2022-07-08 中国工程物理研究院激光聚变研究中心 一种新冠病毒拉曼标记型抗原检测试纸条及其制备方法
CN115792216B (zh) * 2022-11-25 2023-11-03 中国农业科学院北京畜牧兽医研究所 用于检测毒素的侧向层析试纸条、制备方法和使用方法
CN116338169A (zh) * 2022-12-26 2023-06-27 北京科技大学 以微球反射镜作为探针的显微分析方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4920046A (en) * 1987-02-20 1990-04-24 Becton, Dickinson And Company Process, test device, and test kit for a rapid assay having a visible readout
CA1303983C (en) * 1987-03-27 1992-06-23 Robert W. Rosenstein Solid phase assay
USRE38430E1 (en) * 1987-03-27 2004-02-17 Becton, Dickinson And Company Solid phase chromatographic immunoassay
ES2150428T3 (es) * 1987-04-27 2000-12-01 Unilever Nv Ensayos de union especifica.
CA1313616C (en) * 1987-06-01 1993-02-16 Robert B. Sargeant Lateral flow, non-bibulous membrane protocols
AU2684488A (en) 1988-06-27 1990-01-04 Carter-Wallace, Inc. Test device and method for colored particle immunoassay
US6818199B1 (en) * 1994-07-29 2004-11-16 James F. Hainfeld Media and methods for enhanced medical imaging
US6194220B1 (en) 1996-09-25 2001-02-27 Becton, Dickinson And Company Non-instrumented assay with quantitative and qualitative results
US5998221A (en) 1996-09-25 1999-12-07 Becton, Dickinson And Company Non-instrumented assay with quantitative and qualitative results
US5798273A (en) * 1996-09-25 1998-08-25 Becton Dickinson And Company Direct read lateral flow assay for small analytes
JP2001502052A (ja) * 1996-09-25 2001-02-13 ユニバーサル ヘルスウォッチ,インコーポレーテッド 液体移動および干渉に対する抵抗を改良した診断用検査デバイス
EP1062510A2 (en) * 1998-03-10 2000-12-27 Strategic Diagnostics Inc. Integrated assay device and methods of production and use
US6136610A (en) * 1998-11-23 2000-10-24 Praxsys Biosystems, Inc. Method and apparatus for performing a lateral flow assay
WO2000031538A1 (en) * 1998-11-23 2000-06-02 Praxsys Biosystems, Inc. Improved lateral flow assays
WO2001018235A2 (en) * 1999-09-09 2001-03-15 Eichrom Technologies, Inc. Lateral flow device with metal oxide indicator and assay method employing same
ES2296648T3 (es) 1999-10-06 2008-05-01 Oxonica Inc. Nanoparticulas compuestas espectroscopicamente activas superficialmente potenciadas.
US7052831B2 (en) * 2000-09-29 2006-05-30 Becton Dickinson And Company Detection of multiple analytes from a single sample using a multi-well, multi-analyte flow-through diagnostic test device
ATE421570T1 (de) * 2002-06-07 2009-02-15 Cholestech Corp Automatisierte kassette für eine vorrichtung zur durchführung von immunoanalytischen tests und verfahren zu ihrer verwendung
WO2004081568A1 (ja) * 2003-03-10 2004-09-23 Daiichi Pure Chemicals Co. Ltd. 検体の検査方法及びその検査方法に用いる検体収容用容器
US7659107B2 (en) * 2003-09-23 2010-02-09 Epinex Diagnostics, Inc. Rapid test for glycated albumin
US20050148100A1 (en) * 2003-12-30 2005-07-07 Intel Corporation Methods and devices for using Raman-active probe constructs to assay biological samples
JP2006071520A (ja) * 2004-09-03 2006-03-16 Enbiotec Laboratories:Kk Pcbの簡易検出方法
US7723100B2 (en) 2006-01-13 2010-05-25 Becton, Dickinson And Company Polymer coated SERS nanotag
WO2007090058A2 (en) * 2006-01-27 2007-08-09 Oxonica, Inc. Lateral flow immunoassay with encapsulated detection modality

Also Published As

Publication number Publication date
CN107561270B (zh) 2019-06-04
JP2011516889A (ja) 2011-05-26
JP2015148629A (ja) 2015-08-20
CN102016585A (zh) 2011-04-13
CN107561270A (zh) 2018-01-09
US20090305231A1 (en) 2009-12-10
BRPI0911067A2 (pt) 2015-12-29
CA2721064A1 (en) 2009-10-15
JP5792614B2 (ja) 2015-10-14
JP6379149B2 (ja) 2018-08-22
ES2544257T3 (es) 2015-08-28
BRPI0911067B1 (pt) 2020-10-20
EP2271939B1 (en) 2015-06-17
EP2952897A1 (en) 2015-12-09
AU2009233755A1 (en) 2009-10-15
WO2009126735A1 (en) 2009-10-15
CN102016585B (zh) 2017-10-10
EP2952897B1 (en) 2017-03-22
US20130281310A1 (en) 2013-10-24
JP2017015732A (ja) 2017-01-19
AU2009233755B2 (en) 2015-11-26
ES2627190T3 (es) 2017-07-27
CA2721064C (en) 2016-11-01
MX2010011176A (es) 2011-02-24
TW200946913A (en) 2009-11-16
EP2271939A1 (en) 2011-01-12

Similar Documents

Publication Publication Date Title
BRPI0911067B8 (pt) métodos e sistemas para determinar a presença ou ausência de um analito em uma amostra de líquido
BRPI0912751A2 (pt) métodos de análise e avaliação de um objeto com um sistema de laser de ultra som e instrumento para inspecionar um objeto.
BR112014025384A8 (pt) método e sistema para executar ensaio automatizado e métodos para executar teste reflexivo em vários exemplares
MX2014003153A (es) Prediccion de riesgo de evento cardiovascular y usos del mismo.
BRPI0720707A2 (pt) Sistema de teste para uso com um tampão para testar a presença de moléculas alvo de um ou mais tipos de alvo em uma amostra de teste biológico; sistema de teste para testar a presença de moléculas alvo de um ou mais tipos de alvo em uma amostra de teste biológico; e método de focalização de moléculas para facilitar um teste da presença de moléculas alvo de um ou mais tipos de alvo de uma amostra de teste biológico.
WO2009117168A3 (en) Detection of analytes using metal nanoparticle probes and dynamic light scattering
BR112013012501A2 (pt) método e sistema de teste de analito com notificação de tendências de analito altas e baixas
BR112012020251A2 (pt) dispositivo de análise para a aquisição de amostra, tratamento e reação
WO2009121032A3 (en) Sample preparation devices and methods for processing analytes
WO2014058760A3 (en) Preloaded test substrates for testing lal-reactive substances, methods of use, and methods of making
BRPI0911863A2 (pt) método para determinar a presença de um analito em uma amostra de estrutura queratinizada de um indivíduo.
WO2010065781A3 (en) Lateral flow strip assay with immobilized conjugate
BR112012029281A2 (pt) anticorpo trop-2 anti-humano tendo atividade anti-tumor in vivo
CR20110241A (es) Método para inducir pluripotencia en células
CR20110567A (es) Dispositivos para diagnostico y metodos relacionados
BRPI0912305A2 (pt) analisador químico, método para análise baseada em amostra, dispositivo para manipulação de cuvetas e método de carregamento.
BRPI1014652A2 (pt) sensor eletroquímico amperométrico, método para fabricar o mesmo, sonda amperométrica de medição do teor de uma substância de oxirredução dissolvida em um líquido e uso de um sensor.
WO2008111464A1 (ja) スプライシング異常を指標とする抗ガン剤の作用検定方法
EA201391627A1 (ru) Анализ на наличие лизилоксидазоподобных белков 2 и способы его применения
BR122019018448B8 (pt) método para extração de succinilacetona e um ou mais analitos biológicos adicionais
WO2007113838A3 (en) Device, system and method for in-vivo analysis
WO2009023331A3 (en) Antibodies and improved test sample handling methods for use in assays for myeloperoxidase
DK2129391T3 (da) Diagnostisk fremgangsmåde
BR112012010273A2 (pt) composição, dispositivo, método e artigo para detecção de um analito em uma amostra por leitura óptica colorimétrica, e, uso da composição
AP2011005905A0 (en) Device and method for the verification and quantitative analysis of analytes, particularly mycotoxins.

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 20/10/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 08/04/2009, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO